InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Meeter Dalen. Director active across 1 company, notably Singular Genomics Systems, Inc.. Aggregated, 12 disclosures have been recorded. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Meeter Dalen is linked to Singular Genomics Systems, Inc. (XNAS) as Chief Financial Officer. The declarant has 12 filings in total, and the sampled recent filings cover the period from 2023-06-20 to 2025-02-25, with the most frequent transaction nature shown as option exercise.